eli lilly compounded tirzepatide Impurity in Some 'Potentially Dangerous,' Warns Eli Lilly hits out against

Certain formulations are FDA-approved to lower the risk of serious cardiovascular events, such as heart attacks and strokes, in adults with heart disease who are overweight or obese

INDICATIONS FOR NOVEL ANTIDIABETIC MEDICATIONS GLP-1RAs and dual GIP/GLP-1 receptor agonists are approved for two main indications: T2DM and obesity

A thorough medical evaluation is essential before initiating therapy

Serious adverse events in the Phase 2 trial were low

The level of eGFR can help detect early CKD, and decreasing levels of eGFR are considered the most characteristic sign of progressive kidney disease

The higher the C rating, usually the more expensive and slightly heavier the battery gets